血液および血液成分の世界市場

血液および血液成分の世界市場は2030年までに148億米ドルに到達

2024年に130億米ドルと推定される血液および血液成分の世界市場は、2024年から2030年にかけてCAGR 2.2%で成長し、2030年には148億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである血液成分は、CAGR 2.8%を記録し、分析期間終了時には86億米ドルに達すると予想されます。全血種セグメントの成長率は、分析期間中CAGR 1.5％と推定されます。

米国市場は35億米ドルと推定、中国はCAGR 4.4％で成長すると予測

米国の血液および血液成分市場は2024年に35億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに28億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.7％と1.7％と予測されています。欧州では、ドイツがCAGR 1.2%で成長すると予測されています。

世界の血液および血液成分市場- 主要動向と促進要因のまとめ

なぜ血液および血液成分の需要がヘルスケアシステム全体で高まっているのか？

血液および血液成分は現代医療において重要な役割を果たしており、手術、外傷治療、がん治療、慢性疾患管理などにおいて救命治療製品としての役割を果たしています。貧血、血友病、白血病、その他の血液疾患などの有病率の増加に伴い、赤血球（RBC）、血小板、血漿、凝固因子を含む血液製剤の世界的需要は増加の一途をたどっています。さらに、臓器移植、複雑な手術、積極的な化学療法などの医療処置の進歩により、安定的かつ効率的な血液供給の必要性がさらに高まっています。

輸血は、特に事故や戦場での負傷、出産時の母体出血に対応するため、依然として救急医療の基本的な要素となっています。さらに、血液関連疾患にかかりやすい老年人口の増加が、血液成分への依存度を高める一因となっています。需要の高まりにもかかわらず、血液不足、ドナー確保、輸血感染症（TTI）に対する懸念などの課題は依然として残っています。これらの問題に対処するため、ヘルスケア機関、血液銀行、バイオテクノロジー企業は、人工血液代替品、病原体削減技術、高度な血液保存技術などの革新的な解決策を模索しています。

技術の進歩はどのように採血、処理、保存を向上させているのか？

血液処理と輸血医療における技術革新は、安全性、効率性、そして血液および血液成分の利用可能性を著しく向上させています。最もインパクトのある進歩のひとつは、血液製剤からウイルス、細菌、寄生虫を除去し、輸血による感染症のリスクを軽減する病原体除去技術（PRT）の開発です。UV光による病原体不活化、溶媒-洗剤による血漿処理など、これらの治療技術は、世界中で輸血の安全性を高めています。

血漿、血小板、赤血球などの特定の血液成分を選択的に採取し、残りの血液をドナーに戻すことができます。アフェレーシスは、ドナーの維持率を向上させるだけでなく、全血献血の必要性を減らすことによって採血効率を高める。さらに、凍結保存や血液の長期保存技術の進歩は、サプライチェーンの課題に対処し、特に遠隔地や災害の多い地域において、血液成分がより長期間生存可能であることを保証しています。ヘモグロビンベースの酸素運搬体（HBOC）やパーフルオロカーボンベース（PFC）の代用血液を含む、現在進行中の合成血液の開発は、緊急輸血や軍事用途に有望であり、ドナー血液供給への依存を低減できる可能性があります。

血液および血液成分業界の成長を牽引する市場動向は？

世界の血液および血液成分市場は、疾病の蔓延、外科手術の増加、ヘルスケアインフラの改善などが相まって拡大しています。業界を形成する最も顕著な動向の1つは、血漿由来療法が重視されるようになっていることです。血漿分画は、免疫不全障害、血友病、神経疾患の治療に血漿由来製品が不可欠であることから、重要な投資分野となっています。免疫グロブリン、アルブミン、凝固因子の需要が高まる中、バイオ医薬品企業は血漿採取ネットワークを拡大し、大規模な分画施設に投資しています。

市場に影響を与えるもう一つの主要動向は、自発的かつ無報酬の献血政策へのシフトです。多くの国が、啓発キャンペーン、インセンティブ、デジタル関与戦略を通じて、ドナーの募集と維持を改善する取り組みを実施しています。さらに、血液サプライチェーンにおけるブロックチェーンとデジタル追跡システムの統合は、透明性を高め、無駄を削減し、血液バンキングにおけるトレーサビリティを向上させています。個別化医療や再生医療の拡大も、手術やがん治療の際に患者自身の血液を採取して再注入する自己血輸血への関心を高めています。ヘルスケア・システムが効率性と安全性を優先する中、デジタル血液管理ソリューションと高度なドナー・スクリーニング技術の採用により、血液の収集と分配がさらに合理化されると予想されます。

血液および血液成分市場の将来を形作る主な成長促進要因とは？

血液および血液成分市場の成長は、慢性疾患の負担の増加、輸血医療の進歩、血液の安全性とサプライチェーンの最適化に対する投資の増加など、いくつかの重要な要因によってもたらされます。主な成長要因の1つは、外科手術や外傷症例の拡大で、信頼性の高い血液供給が必要とされています。世界中で選択手術や緊急手術の件数が増加しているため、病院やヘルスケアプロバイダーは、重要な治療中に血液を確保できるよう、血液バンクや輸血サービスに投資しています。

市場を形成するもう一つの重要な促進要因は、血漿由来の治療薬に対する需要の高まりです。バイオ医薬品業界は、免疫不全治療、血友病治療、血漿をベースとした新規治療に注力しているため、血漿収集の取り組みが活発化し、遺伝子組換え治療薬の研究が進められています。さらに、核酸検査（NAT）やAIを活用したリスク評価モデルなど、高度なドナースクリーニング技術の採用により、血液の安全性が向上し、輸血関連合併症の発生率が低下しています。各国政府とヘルスケア機関が献血、処理、輸血の実施に関する規制の枠組みを強化する中、市場は継続的に拡大する態勢を整えています。合成血液代替品、病原体削減戦略、デジタルヘルス統合における継続的な技術革新により、血液および血液成分業界の将来は、安全性、効率性、アクセシビリティの強化によって定義され、世界中でより良い患者転帰が保証されます。

セグメント

製品タイプ（血液成分、全血タイプ）、用途（貧血用途、外傷・手術用途、がん治療用途、出血性疾患用途、その他用途）、最終用途（病院、外来手術センター、その他）

調査対象企業の例

• American Association of Blood Banks（AABB）
• American Red Cross
• Australian Red Cross
• Baxter International Inc.
• Beckman Coulter, Inc.
• Bio Products Laboratory（BPL）
• bioMerieux SA
• Cerus Corporation
• CSL Limited
• European Blood Alliance
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Hualan Biological Engineering Inc.
• Immucor, Inc.
• Indian Red Cross Society
• Kedrion Biopharma
• Maco Pharma International GmbH
• Mitsubishi Tanabe Pharma Corporation
• Octapharma AG
• South African National Blood Service
• Takeda Pharmaceutical Company Limited
• Teleflex Incorporated
• Terumo Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Blood and Blood Components Market to Reach US$14.8 Billion by 2030

The global market for Blood and Blood Components estimated at US$13.0 Billion in the year 2024, is expected to reach US$14.8 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Blood Components, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Whole Blood Type segment is estimated at 1.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 4.4% CAGR

The Blood and Blood Components market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Blood and Blood Components Market - Key Trends & Drivers Summarized

Why Is the Demand for Blood and Blood Components Increasing Across Healthcare Systems?

Blood and blood components play a critical role in modern medicine, serving as life-saving therapeutic products in surgeries, trauma care, cancer treatments, and chronic disease management. With the increasing prevalence of conditions such as anemia, hemophilia, leukemia, and other hematologic disorders, the global demand for blood products-including red blood cells (RBCs), platelets, plasma, and clotting factors-continues to rise. Additionally, advancements in medical procedures, including organ transplants, complex surgeries, and aggressive chemotherapy treatments, have further elevated the need for a stable and efficient blood supply.

Blood transfusion remains a fundamental component of emergency medicine, particularly in response to accidents, battlefield injuries, and maternal hemorrhage during childbirth. Moreover, the growing geriatric population, which is more susceptible to blood-related disorders, has contributed to an increasing reliance on blood components. Despite the rising demand, challenges such as blood shortages, donor recruitment, and concerns over transfusion-transmitted infections (TTIs) persist. To address these issues, healthcare organizations, blood banks, and biotech firms are exploring innovative solutions, including artificial blood substitutes, pathogen reduction technologies, and advanced blood storage techniques.

How Are Technological Advancements Enhancing Blood Collection, Processing, and Storage?

Innovations in blood processing and transfusion medicine are significantly improving the safety, efficiency, and availability of blood and blood components. One of the most impactful advancements is the development of pathogen reduction technologies (PRTs), which help eliminate viruses, bacteria, and parasites from blood products, reducing the risk of transfusion-transmitted infections. These technologies, including UV light-based pathogen inactivation and solvent-detergent plasma treatment, are enhancing the safety profile of blood transfusions worldwide.

Another breakthrough in the blood industry is the introduction of automated apheresis systems, which allow for the selective collection of specific blood components such as plasma, platelets, or red blood cells while returning the remaining blood to the donor. Apheresis not only improves donor retention but also increases the efficiency of blood collection by reducing the need for whole blood donations. Additionally, advancements in cryopreservation and extended blood storage techniques are addressing supply chain challenges, ensuring that blood components remain viable for longer durations, especially in remote or disaster-stricken regions. The ongoing development of synthetic blood substitutes, including hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon-based (PFC) blood substitutes, holds promise for emergency transfusions and military applications, potentially reducing dependency on donor blood supplies.

Which Market Trends Are Driving Growth in the Blood and Blood Components Industry?

The global blood and blood components market is expanding due to a combination of rising disease prevalence, increasing surgical procedures, and improvements in healthcare infrastructure. One of the most prominent trends shaping the industry is the growing emphasis on plasma-derived therapies. Plasma fractionation has become a key area of investment, as plasma-derived products are essential in treating immunodeficiency disorders, hemophilia, and neurological conditions. With rising demand for immunoglobulins, albumin, and clotting factors, biopharmaceutical companies are expanding plasma collection networks and investing in large-scale fractionation facilities.

Another key trend influencing the market is the shift toward voluntary and non-remunerated blood donation policies. Many countries are implementing initiatives to improve donor recruitment and retention through awareness campaigns, incentives, and digital engagement strategies. Additionally, the integration of blockchain and digital tracking systems in blood supply chains is enhancing transparency, reducing wastage, and improving traceability in blood banking. The expansion of personalized medicine and regenerative therapies is also driving interest in autologous blood transfusions, where a patient’s own blood is collected and reinfused during surgeries or cancer treatments. As healthcare systems prioritize efficiency and safety, the adoption of digital blood management solutions and advanced donor screening techniques is expected to further streamline blood collection and distribution.

What Are the Key Growth Drivers Shaping the Future of the Blood and Blood Components Market?

The growth in the blood and blood components market is driven by several critical factors, including the increasing burden of chronic diseases, advancements in transfusion medicine, and rising investments in blood safety and supply chain optimization. One of the primary growth drivers is the expanding number of surgical procedures and trauma cases, necessitating a reliable blood supply. With an increasing number of elective and emergency surgeries being performed worldwide, hospitals and healthcare providers are investing in blood banking and transfusion services to ensure availability during critical interventions.

Another crucial driver shaping the market is the growing demand for plasma-derived therapeutics. The biopharmaceutical industry’s focus on immunodeficiency treatments, hemophilia care, and novel plasma-based therapies has led to increased plasma collection efforts and research into recombinant alternatives. Additionally, the adoption of advanced donor screening technologies, including nucleic acid testing (NAT) and AI-driven risk assessment models, is improving blood safety and reducing the incidence of transfusion-related complications. As governments and healthcare organizations strengthen regulatory frameworks for blood donation, processing, and transfusion practices, the market is poised for continued expansion. With ongoing innovations in synthetic blood substitutes, pathogen reduction strategies, and digital health integration, the future of the blood and blood components industry will be defined by enhanced safety, efficiency, and accessibility, ensuring better patient outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Blood and Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Blood Components, Whole Blood Type); Application (Anemia Application, Trauma and Surgery Application, Cancer Treatment Application, Bleeding Disorders Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• American Association of Blood Banks (AABB)
• American Red Cross
• Australian Red Cross
• Baxter International Inc.
• Beckman Coulter, Inc.
• Bio Products Laboratory (BPL)
• bioMerieux SA
• Cerus Corporation
• CSL Limited
• European Blood Alliance
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Hualan Biological Engineering Inc.
• Immucor, Inc.
• Indian Red Cross Society
• Kedrion Biopharma
• Maco Pharma International GmbH
• Mitsubishi Tanabe Pharma Corporation
• Octapharma AG
• South African National Blood Service
• Takeda Pharmaceutical Company Limited
• Teleflex Incorporated
• Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Blood and Blood Components - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Demand for Transfusion Therapies Throws the Spotlight on Blood and Blood Component Supply Chains
  • Growth in Surgical Procedures and Trauma Cases Drives Steady Demand for Red Blood Cells and Whole Blood Products
  • Expansion of Hematological and Oncology Treatments Strengthens the Business Case for Platelet and Plasma Component Utilization
  • Aging Population and Associated Chronic Diseases Fuel Long-Term Demand for Blood-Based Therapeutics
  • Increasing Use of Plasma-Derived Medicinal Products (PDMPs) Expands Addressable Market Opportunity for Plasma Collection and Processing
  • Technological Advancements in Apheresis and Component Separation Enhance Efficiency and Product Quality
  • Growing Awareness and Adoption of Patient Blood Management (PBM) Programs Spur Rational Use of Blood Components
  • Development of Recombinant and Synthetic Alternatives Creates a Balancing Dynamic in Blood Component Markets
  • Rise in Voluntary Blood Donation Campaigns Strengthens Public Health Infrastructure in Emerging Economies
  • Increasing Prevalence of Rare Blood Disorders and Autoimmune Conditions Generates Demand for Specialized Component Therapies
  • Integration of Pathogen Reduction Technologies (PRT) Enhances Safety and Shelf-Life of Blood Components
  • Growth of Cell Therapy and Regenerative Medicine Markets Opens New Avenues for Blood-Derived Cellular Components
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Blood and Blood Components Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Blood and Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Whole Blood Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Whole Blood Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Whole Blood Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Anemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Trauma & Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Trauma & Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Trauma & Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Cancer Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Cancer Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Cancer Treatment Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Bleeding Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Blood and Blood Components by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Blood and Blood Components by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Blood and Blood Components by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Blood and Blood Components by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION